Timken CTO reports RSU vesting and share withholding

Timken Chief Technology Officer John Raymond Szarka reported equity award activity in company common stock.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Timken Chief Technology Officer John Raymond Szarka reported equity award activity in company common stock. On February 10, 2026, he acquired 168 shares of common stock at $0 per share, reflecting vesting of 25% of time-based restricted share units originally granted on February 10, 2022.

On the same date, 58 shares of common stock were disposed of at $109.23 per share to cover tax obligations through share withholding. Following these transactions, Szarka directly owned 2,843 shares of Timken common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Szarka John Raymond

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	168	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	58	$109.23	$6K

Holdings After Transaction: Common Stock — 2,843 shares (Direct)

Footnotes (1)

F1. Represents vesting of 25% of the time-based restricted share units granted on February 10, 2022.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Timken (TKR) report for CTO John Raymond Szarka?

Timken reported that CTO John Raymond Szarka had 168 common shares acquired from vesting restricted share units and 58 shares withheld to cover taxes. These routine equity award-related transactions left him directly holding 2,843 Timken common shares afterward.

How many Timken (TKR) shares did the CTO acquire in the latest Form 4?

The CTO acquired 168 Timken common shares at $0 per share through the vesting of restricted share units. This vesting represented 25% of a time-based restricted share unit grant originally awarded on February 10, 2022.

Why were some Timken (TKR) shares disposed of in John Raymond Szarka’s filing?

The filing shows 58 Timken common shares disposed of at $109.23 per share to satisfy tax obligations. This was reported under transaction code F, which indicates payment of tax liability or exercise price by delivering securities rather than an open-market sale.

How many Timken (TKR) shares does the CTO hold after these transactions?

After the reported transactions, CTO John Raymond Szarka directly holds 2,843 Timken common shares. This balance reflects both the 168 shares acquired from restricted share unit vesting and the 58 shares withheld to cover associated tax liabilities on February 10, 2026.

What is the nature of the equity award that vested for Timken (TKR) CTO Szarka?

The equity award involves time-based restricted share units granted on February 10, 2022. The current Form 4 notes that 25% of those restricted share units vested on February 10, 2026, resulting in the issuance of 168 Timken common shares to the executive.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/12/2026 - 06:03 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Szarka John Raymond

(Last)

(First)

(Middle)

4500 MOUNT PLEASANT ST. NW

(Street)

NORTH CANTON

44720

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
TIMKEN CO [ TKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾	02/10/2026		A		168	A	$0	2,901	D
Common Stock	02/10/2026		F		58	D	$109.23	2,843	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents vesting of 25% of the time-based restricted share units granted on February 10, 2022.

Remarks:

	/s/ John R. Szarka	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR